Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)

This study has been terminated.
Sponsor:
Information provided by:
FibroGen
ClinicalTrials.gov Identifier:
NCT00782561
First received: October 27, 2008
Last updated: July 14, 2009
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: March 2011
  Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)